Skip to main content

Advertisement

Log in

Cognitive Impairment in Fibromyalgia

  • Fibromyalgia (M Peres, Section Editor)
  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

Cognitive and behavioral impairments are core manifestations of fibromyalgia and may be more disabling than pain itself. Involvement of the central nervous system is ascertained by the fact that frontoparietal and limbic cortices are often functionally and structurally affected along the course of this disease. Even though neuroimaging has brought some experimental evidence to support such network disruption, there are currently no clinically effective biomarkers that detect and quantify cognitive and behavioral disturbances in fibromyalgia; thus, traditional scales and tests of neuropsychiatric assessment remain the most important diagnostic tools. This review addresses the most common cognitive and behavioral impairments in people with fibromyalgia, while explaining their pathophysiological basis and currently available therapeutic options.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Recently published papers of particular interest have been highlighted as:• Of importance •• Of major importance

  1. Smith HS, Harris R, Clauw D. Fibromyalgia: An Afferent Processing Disorder Leading to a Complex Pain Generalized Syndrome. Pain Physician. 2011;14:E217–45.

    PubMed  Google Scholar 

  2. • Can SS, Gencay-Can A, Gunendi Z. Validity and reliability of the clock drawing test as a screening tool for cognitive impairment in patients with fibromyalgia. Comprehensive Psychiatry. 2012;53:81–6. This study correlates different scoring methods of the clock drawing test with the Mini-Mental State Examination, demonstrating good reliability for screening of cognitive impairment in patients with fibromyalgia.

    Article  PubMed  Google Scholar 

  3. Matsuda JB, Barbosa FR, Morel LJF, et al. Serotonin receptor (5-HT 2A) and catechol-O-methyltransferase (COMT) gene polymorphisms: Triggers of fibromyalgia? Bras J Rheumatol. 2010;50:141–9.

    Google Scholar 

  4. Torres X, Bailles E, Collado A, et al. The Symptom Checklist-Revised (SCL-90-R) is Able to Discriminate Between Simulation and Fibromyalgia. J Clin Psychol. 2010;66:774–90.

    PubMed  Google Scholar 

  5. Cherry BJ, Weiss J, Barakat BK, Rutledge DN, Jones CJ. Physical Performance as a Predictor of Attention and Processing Speed in Fibromyalgia. Arch Phys Med Rehabil. 2009;90:2066–73.

    Article  PubMed  Google Scholar 

  6. • Mease PJ, Dundon K, Sarzi-Puttini P. Pharmacotherapy of fibromyalgia. Best Pract Res Clin Rheumatol. 2011;25:285–97. A comprehensive review of currently approved pharmacological agents for fibromyalgia, including details on the pathophysiological mechanisms of the disease.

    Article  PubMed  CAS  Google Scholar 

  7. Ravindran MK, Zheng Y, Timbol C, Merck SJ, Baraniuk JN. Migraine headaches in Chronic Fatigue Syndrome (CFS): Comparison of two prospective cross-sectional studies. BMC Neurol. 2011;11:30.

    Article  PubMed  Google Scholar 

  8. • Finan PH, Zautra AJ, Davis MC, et al. COMT moderates the relation of daily maladaptive coping and pain in fibromyalgia. Pain. 2011;152:300–7. Homozygous met 158 female carriers in relation to polymorphism rs4680 of the COMT gene evidenced more pain on days when pain attention was elevated in view of the low catechol-O-methyltransferase enzymatic activity, suggesting that genetic variation in this polymorphism may affect pain in patients with fibromyalgia through pathways of pain-related cognition.

    Article  PubMed  Google Scholar 

  9. Martínez MP, Sánchez AI, Miró E, Medina A, Lami MJ. The Relationship Between the Fear-Avoidance Model of Pain and Personality Traits in Fibromyalgia Patients. J Clin Psychol Med Settings. 2011;18:380–91.

    Article  PubMed  Google Scholar 

  10. Alda M, Luciano JV, Andrés E, et al. Effectiveness of cognitive behaviour therapy for the treatment of catastrophisation in patients with fibromyalgia: a randomised controlled trial. Arthritis Res Ther. 2011;13:R173.

    Article  PubMed  Google Scholar 

  11. Napadow V, LaCount L, Park K, et al. Intrinsic Brain Connectivity in Fibromyalgia Is Associated With Chronic Pain Intensity. Arthritis Rheum. 2010;62:2545–55.

    Article  PubMed  Google Scholar 

  12. Miró E, Martínez MP, Sánchez AI, Prados G, Medina A. When is pain related to emotional distress and daily functioning in fibromyalgia syndrome? The mediating roles of self-efficacy and sleep quality. Br J Heal Psychol. 2011;16:799–814.

    Article  Google Scholar 

  13. •• Olama SM, Senna MK, Elarman MM, Elhawary G. Serum vitamin D level and bone mineral density in premenopausal Egyptian women with fibromyalgia. Rheumatol Int. 2013;33:185–92. Women with fibromyalgia are more prone to develop hypovitaminosis D, which has been correlated not only with osteoporosis, but also with impaired cognition, sleep disruption and mood disorders.

    Article  PubMed  CAS  Google Scholar 

  14. • Melo LF, Da-Silva SL. Neuropsychological assessment of cognitive disorders in patients with fibromyalgia, rheumatoid arthritis, and systemic lupus erythematosus. Rev Bras Reumatol. 2012;52:175–88. This paper shows that cognitive impairment is a frequent manifestation of rheumatological disorders, while patients with fibromyalgia and systemic lupus erythematosus displayed anxiety, irritability and hallucinations more frequently than patients with rheumatoid arthritis in the neuropsychiatric inventory.

    Article  Google Scholar 

  15. Ceko M, Bushnell MC, Gracely RH: Neurobiology Underlying Fibromyalgia Symptoms. Pain Research and Treatment 2012, 585419.

  16. •• Wolfe F, Clauw DJ, Fitzcharles M-A, et al. Fibromyalgia Criteria and Severity Scales for Clinical and Epidemiological Studies: A Modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol. 2011;38:1113–22. This article demonstrates the development of a self-assessment questionnaire for patients with fibromyalgia by modifying the 2010 American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia, but the weight of cognitive impairment on the overall diagnostic criteria is kept low.

    Article  PubMed  Google Scholar 

  17. Rodríguez-Andreu J, Ibáñez-Bosch R, Portero-Vázquez A, et al. Cognitive impairment in patients with Fibromyalgia syndrome as assessed by the Mini-Mental State Examination. BMC Musculoskelet Disord. 2009;10:162.

    Article  PubMed  Google Scholar 

  18. Kool MB, van Middendorp H, Lumley MA, et al. Lack of understanding in fibromyalgia and rheumatoid arthritis: the Illness Invalidation Inventory (3*I). Ann Rheum Dis. 2010;69:1990–5.

    Article  PubMed  CAS  Google Scholar 

  19. Geisser ME, Clauw DJ, Strand V, et al. Contributions of change in clinical status parameters to Patient Global Impression of Change (PGIC) scores among persons with fibromyalgia treated with milnacipran. Pain. 2010;149:373–8.

    Article  PubMed  Google Scholar 

  20. Beck AT. Depression: causes and treatment. Philadelphia: University of Pennsylvania Press; 1972.

    Google Scholar 

  21. Smets EM, Garssen B, Bonke B, De Haes JC. The Multidimensional Fatigue Inventory (MFI): psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39:315–25.

    Article  PubMed  CAS  Google Scholar 

  22. Sullivan MJL, Bishop S, Pivik J. The Pain Catastrophizing Scale: Development and validation. Psychol Assess. 1995;7:524–32.

    Article  Google Scholar 

  23. Seidenberg M, Haltiner A, Taylor MA, Hermann BB, Wyler A. Development and validation of a Multiple Ability Self-Report Questionnaire. J Clin Exp Neuropsychol. 1994;16:93–104.

    Article  PubMed  CAS  Google Scholar 

  24. •• Arnold LM, Williams DA, Hudson JI, et al. Development of Responder Definitions for Fibromyalgia Clinical Trials. Arthritis Rheum. 2012;64:885–94. This paper shows that the most sensitive responder definitions for patients with fibromyalgia are: over 30 % reduction in pain and over 10 % improvement in physical function. The absence of cognitive or behavioral measures may reflect a lack of proper methods for their assessment.

    Article  PubMed  Google Scholar 

  25. • Gracely RH, Ambrose KR. Neuroimaging of fibromyalgia. Best Pract Res Clin Rheumatol. 2011;25:271–84. A comprehensive review on the experimental value of currently available neuroimaging methods for patients with fibromyalgia.

    Article  PubMed  Google Scholar 

  26. Puri BK, Agour M, Gunatilake KDR, et al. Reduction in Left Supplementary Motor Area Grey Matter in Adult Female Fibromyalgia Sufferers with Marked Fatigue and without Affective Disorder: a Pilot Controlled 3-T Magnetic Resonance Imaging Voxel-based Morphometry Study. The Journal of International Medical Research. 2010;38:1468–72.

    Article  PubMed  CAS  Google Scholar 

  27. • Diers M, Yilmaz P, Rance M, et al. Treatment-related changes in brain activation in patients with fibromyalgia syndrome. Exp Brain Res. 2012;218:619–28. Behavioral extinction training reduces both interference related to pain and pain severity in significant association with bilateral pain-evoked activity in the posterior insula and the basal nuclei, along with the primary somatosensory cortex contralateral to the stimulated side.

    Article  PubMed  CAS  Google Scholar 

  28. • Fayed N, Andres E, Rojas G, et al. Brain dysfunction in fibromyalgia and somatization disorder using proton magnetic resonance spectroscopy: a controlled study. Acta Psychiatr Scand. 2012;126:115–25. This small study provides evidence of increased levels of a combined measure of glutamate and glutamine within the posterior cingulate cortex in patients with fibromyalgia and somatization disorder compared with controls, suggesting that catastrophisation, which is also correlated with such levels, may be associated with the glutamatergic activity in this brain area.

    Article  PubMed  CAS  Google Scholar 

  29. •• Becker S, Kleinböhl D, Baus D, Hölzl R. Operant learning of perceptual sensitization and habituation is impaired in fibromyalgia patients with and without irritable bowel syndrome. Pain. 2011;152:1408–17. This paper demonstrates that operant perceptual conditioning is impaired in patients with fibromyalgia, while impairments in both enhanced perceptual sensitization and habituation depend on the presence of comorbid irritable bowel syndrome.

    Article  PubMed  Google Scholar 

  30. • Kim S-H, Kim S-H, Kim S-K, et al. Spatial versus verbal memory impairments in patients with fibromyalgia. Rheumatol Int. 2012;32:1135–42. This study compared female patients with fibromyalgia and healthy controls, and found a heterogeneous impairment of cognitive functions, suggesting that visuospatial memory abilities may be more impaired than verbal memory in patients with fibromyalgia.

    Article  PubMed  Google Scholar 

  31. • Cherry BJ, Zettel-Watson L, Chang JC, et al. Positive associations between physical and cognitive performance measures in fibromyalgia. Arch Phys Med Rehabil. 2012;93:62–71. This study implies that, after controlling for age and symptoms of fibromyalgia, better physical performance (based on assessments, not self-reports) is associated with higher cognitive functioning.

    Article  PubMed  Google Scholar 

  32. Verdejo-García A, López-Torrecillas F, Calandre EP, Delgado-Rodríguez A, Bechara A. Executive Function and Decision-Making in Women with Fibromyalgia. Arch Clin Neuropsychol. 2009;24:113–22.

    Article  PubMed  Google Scholar 

  33. •• Glass JM, Williams DA, Fernandez-Sanchez M-L, et al. Executive Function in Chronic Pain Patients and Healthy Controls: Different Cortical Activation During Response Inhibition in Fibromyalgia. J Pain. 2011;12:1219–29. Patients with fibromyalgia show lower activation in the inhibition network (specifically in areas involved in response selection and motor preparation) and the attention network, along with increased activation in brain areas not normally part of the inhibition network; therefore, inhibition and pain perception may use overlapping networks, while resources taken up by pain processing may be unavailable for other processes such as executive functions.

    Article  PubMed  Google Scholar 

  34. Seo J, Kim S-H, Kim Y-T, et al. Working Memory Impairment in Fibromyalgia Patients Associated with Altered Frontoparietal Memory Network. PLoS One. 2012;7:e37808.

    Article  PubMed  CAS  Google Scholar 

  35. Cánovas R, León I, Roldán MD, Astur R, Cimadevilla JM. Virtual reality tasks disclose spatial memory alterations in fibromyalgia. Rheumatology. 2009;48:1273–8.

    Article  PubMed  Google Scholar 

  36. del Paso GA R, Pulgar A, Duschek S, Garrido S. Cognitive impairment in fibromyalgia syndrome: The impact of cardiovascular regulation, pain, emotional disorders and medication. Eur J Pain. 2012;16:421–9.

    Article  Google Scholar 

  37. Glass JM. Review of Cognitive Dysfunction in Fibromyalgia: A Convergence on Working Memory and Attentional Control Impairments. Rheum Dis Clin N Am. 2009;35:299–311.

    Article  Google Scholar 

  38. Correa A, Miró E, Martínez MP, Sánchez AI, Lupiáñez J. Temporal preparation and inhibitory deficit in fibromyalgia syndrome. Brain Cognition. 2011;75:211–6.

    Article  Google Scholar 

  39. Walteros C, Sánchez-Navarro JP, Muñoz MA, et al. Altered associative learning and emotional decision making in fibromyalgia. J Psychosom Res. 2011;70:294–301.

    Article  PubMed  Google Scholar 

  40. • Lambin DI, Thibault P, Simmonds M, Lariviere C, Sullivan MJL. Repetition-induced activity-related summation of pain in patients with fibromyalgia. Pain. 2011;152:1424–30. Increased repetition-induced summation of activity-related pain in women with fibromyalgia is positively correlated with fear of movement, and consists on a possible explanation of why such patients show more severe pain-related disability than individuals with chronic low back pain.

    Article  PubMed  Google Scholar 

  41. • Blom D, Thomaes S, Kool MB, et al. A combination of illness invalidation from the work environment and helplessness is associated with embitterment in patients with FM. Rheumatology. 2012;51:347–53. This study shows that embitterment is a function of the joint experience of invalidation from the work environment and helplessness regarding the ill state of patients with fibromyalgia.

    Article  PubMed  Google Scholar 

  42. Schmechel DE, Edwards CL. Fibromyalgia, mood disorders, and intense creative energy: A1AT polymorphisms are not always silent. Neurotoxicology. 2012;33:1454–72.

    Article  PubMed  CAS  Google Scholar 

  43. Auvinet B, Chaleil D, Cabane J, et al. The interest of gait markers in the identification of subgroups among fibromyalgia patients. BMC Musculoskelet Disord. 2011;12:258.

    Article  PubMed  Google Scholar 

  44. Salinsky M, Storzbach D, Munoz S. Cognitive effects of pregabalin in healthy volunteers: A double-blind, placebo-controlled trial. Neurology. 2010;74:755–61.

    Article  PubMed  CAS  Google Scholar 

  45. Salinsky M, Storzbach D, Spencer D, et al. Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers. Neurology. 2005;64:792–8.

    Article  PubMed  CAS  Google Scholar 

  46. Carbonell-Baeza A, Ruiz JR, Aparicio VA, et al. Land- and water-based exercise intervention in women with fibromyalgia: the al-andalus physical activity randomised controlled trial. BMC Musculoskelet Disord. 2012;13:18.

    Article  PubMed  Google Scholar 

  47. • Veldhuijzen DS, Sondaal SFV, Oosterman JM. Intact Cognitive Inhibition in Patients With Fibromyalgia but Evidence of Declined Processing Speed. J Pain. 2012;13:507–15. This study detected that female patients with fibromyalgia performed worse on interference tests than controls, with decreased reaction time performance translating into underlying problems in psychomotor or mental processing speed.

    PubMed  Google Scholar 

  48. Lee DM, Pendleton N, Tajar A, et al. Chronic widespread pain is associated with slower cognitive processing speed in middle-aged and older European men. Pain. 2010;151:30–6.

    Article  PubMed  CAS  Google Scholar 

  49. •• Jensen KB, Kosek E, Wicksell R, et al. Cognitive Behavioral Therapy increases pain-evoked activation of the prefrontal cortex in patients with fibromyalgeia. Pain. 2012;153:1495–503. Female patients treated with Acceptance and Commitment Therapy reported superior improvement of fibromyalgia and improved depression and anxiety symptoms, along with increased activations in the ventrolateral prefrontal cortex and the lateral orbitofrontal cortex, regions associated with executive cognitive control. This suggests that cognitive-behavioral therapy may change the way pain is processed in the brain.

    Article  PubMed  Google Scholar 

  50. • Moseley GL, Flor H. Targeting Cortical Representations in the Treatment of Chronic Pain : A Review. Neurorehabil Neural Repair. 2012;26:646–52. An interesting review of the cortical plasticity mechanisms associated with chronic pain and the therapeutic approaches that have been shown to normalize representations and decrease pain.

    Article  PubMed  Google Scholar 

  51. Miró E, Lupiáñez J, Martínez MP, et al. Cognitive-behavioral therapy for insomnia improves attentional function in fibromyalgia syndrome: A pilot, randomized controlled trial. J Health Psychol. 2011;16:770–82.

    Article  PubMed  Google Scholar 

  52. • Baudic S, Attal N, Mhalla A, et al. Unilateral repetitive transcranial magnetic stimulation of the motor cortex does not affect cognition in patients with fibromyalgia. J Psychiatr Res. 2013;47:72–7. Repetitive transcranial magnetic stimulation applied to the left motor cortex has been employed for analgesic treatment in patients with chronic pain, with no modification of cognitive functions over three months in this small study of non-depressed patients with fibromyalgia.

    Article  PubMed  Google Scholar 

  53. Ramachandran VS, Seckel EL. Using mirror visual feedback and virtual reality to treat fibromyalgia. Medical Hypotheses. 2010;75:495–6.

    Article  PubMed  CAS  Google Scholar 

  54. • Hassett AL, Williams DA. Non-pharmacological treatment of chronic widespread musculoskeletal pain. Best Pract Res Clin Rheumatol. 2011;25:299–309. A good review of nonpharmacological strategies for management of fibromyalgia.

    Article  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Dr. Paulo Henrique Ferreira Bertolucci has received personal compensation for consultancy services to Novartis, Janssen, Lilly and Pfizer.

Dr. Fabricio Ferreira de Oliveira receives a scholarship from CAPES – Coordenação de Aperfeiçoamento de Pessoal de Nível Superior for academic research, and serves as a Healthcare Council Member for Gerson Lehrman Group.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paulo Henrique Ferreira Bertolucci.

Additional information

This article is part of the Topical Collection on Fibromyalgia

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bertolucci, P.H.F., de Oliveira, F.F. Cognitive Impairment in Fibromyalgia. Curr Pain Headache Rep 17, 344 (2013). https://doi.org/10.1007/s11916-013-0344-9

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11916-013-0344-9

Keywords

Navigation